ALLMedicine™ Anovulation Center
Research & Reviews 397 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314638
Reproductive Health; Sarahian N, Sarvazad H et. al.
Jul 28th, 2021 - The most common endocrine and metabolic disorders in premenopausal women is polycystic ovary syndrome (PCOS), characterized by hyperandrogenism, chronic anovulation, and/or ultrasound evidence of small ovarian cysts. Obesity and insulin resistance...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290632
Physiological Reports; Zuchowski Y, Dalmasso C et. al.
Jul 22nd, 2021 - Polycystic ovary syndrome (PCOS) in women is characterized by hyperandrogenemia, obesity, and oligo- or anovulation. In addition, women with PCOS are often obese, with insulin resistance, hyperlipidemia, and elevated blood pressure. The cardiometa...
https://doi.org/10.1007/s10067-021-05850-0 10.1056/NEJM199509283331307 10.1210/jc.2006-0178 10.1093/humupd/dmaa029 10.1210/jc.2005-0628 10.1016/j.metabol.2018.11.002 10.1006/cyto.1996.0178 10.1196/annals.1386.043 10.1530/EC-18-0309 10.1002/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z 10.3109/07435800.2015.1015730 10.1016/j.ejim.2010.06.008 10.1016/S0049-0172(03)00084-2 10.1002/art.11073 10.1210/er.2007-0001 10.1210/edrv.23.1.0456 10.1210/er.2011-1034 10.1210/er.2015-1104 10.1007/s40618-014-0118-1 10.7326/0003-4819-132-12-200006200-00010 10.1046/j.1365-2567.2000.00047.x 10.1002/art.1780340102 10.3389/fimmu.2018.02279 10.1016/j.semarthrit.2013.04.008 10.1136/ard.2003.018325 10.1002/art.1780351107 10.1056/NEJMra1100359 10.1016/j.autrev.2010.09.013 10.1016/j.autrev.2020.102659 10.1371/journal.pone.0164021 10.1007/s10815-014-0237-9 10.1056/NEJMra0707449 10.1002/art.39707 10.1001/jama.2017.16144 10.1001/jama.2013.277669 10.1055/s-0032-1328878
Clinical Rheumatology; Sharmeen S, Nomani H et. al.
Jul 4th, 2021 - Polycystic ovary syndrome (PCOS) causes anovulation and hyperandrogenism. Hormonal imbalance is known to contribute to systemic autoimmune diseases. To examine the frequency of certain rheumatic diseases in PCOS. This retrospective study utilized ...
https://doi.org/10.1186/s12958-021-00765-6 10.1056/NEJMcp1514916 10.1016/j.beem.2006.03.005 10.1210/jcem.87.2.8207 10.1016/j.steroids.2013.04.004 10.1095/biolreprod66.2.297 10.1186/1423-0127-21-2 10.1056/NEJM199806253382603 10.1210/jcem.85.1.6293 10.1136/bmj.327.7421.951 10.3109/09513590.2014.951321 10.1210/er.2005-0018 10.1172/JCI1057 10.1007/s11010-012-1522-5 10.1097/IGC.0b013e31821a2584 10.1210/jc.2002-021072 10.1093/humrep/deh098 10.1016/S0015-0282(16)30062-0 10.1016/j.jsbmb.2010.12.006 10.1016/j.ygyno.2013.12.006 10.18632/oncotarget.7040 10.1016/s0960-0760(00)00127-8 10.1530/rep.1.01089 10.1038/bmt.2012.244 10.2174/0929867325666171205144119 10.1530/eje.0.1380269 10.1016/s1262-3636(03)72785-2 10.1093/humrep/dep466 10.1002/pros.23000 10.1007/s11095-006-9665-2 10.1248/bpb.32.982 10.2174/1871530320666200511073302 10.1177/1933719118820466 10.1210/en.2015-2032 10.1089/ten.TEC.2012.0616 10.7150/ijbs.13109
Reproductive Biology and Endocrinology : RB&E; Ohara M, Yoshida-Komiya H et. al.
Jun 1st, 2021 - Polycystic ovary syndrome (PCOS) causes anovulation and is associated with a reduced clinical pregnancy rate. Metformin, which is widely used for treating PCOS, can lead to successful pregnancy by restoring the ovulation cycle and possibly improvi...
https://doi.org/10.1007/s43032-021-00629-9 10.1093/humrep/dew218 10.5694/j.1326-5377.1991.tb93959.x 10.1093/oxfordjournals.humrep.a138174 10.1016/S0015-0282(16)57793-0 10.1056/NEJM199906103402304 10.1530/REP-19-0402 10.1016/j.fertnstert.2019.02.029 10.21037/atm-20-5463 10.1093/hropen/hox031 10.1016/j.fertnstert.2010.04.063 10.1016/j.fertnstert.2012.09.046 10.1007/s10815-020-01948-7 10.1093/humupd/dmy044 10.1590/S0104-42302011000600020 10.1177/1933719113519169 10.1073/pnas.88.24.11408 10.1210/endo.141.12.7855 10.1095/biolreprod.102.014969 10.1093/humrep/del093 10.17576/jsm-2018-4710-28 10.1177/1933719116648216 10.1002/jcp.24241 10.1002/jcp.26852 10.1016/j.bbrc.2015.12.103 10.1016/S1472-6483(10)60228-3 10.1002/ijgo.12898 10.3109/09513590.2014.989980 10.1007/s00441-020-03171-3 10.1016/j.rbmo.2018.04.043 10.1007/s00109-020-01985-w 10.2147/TACG.S207491 10.1186/s13048-017-0308-5 10.4103/GMIT.GMIT_112_18 10.1016/j.rbmo.2017.12.020 10.1093/biolre/ioy187 10.1210/me.2013-1206 10.1074/jbc.M114.588897 10.3892/mmr.2016.5142 10.1210/jc.2002-021072 10.1007/s10815-013-0088-9 10.1002/dvdy.1209 10.1007/s43032-019-00072-x 10.1095/biolreprod66.2.297 10.1016/j.fertnstert.2005.09.053 10.1016/j.rbmo.2019.03.211 10.1080/09513590.2020.1727433 10.1177/1933719113519169 10.1210/jcem.86.12.8088 10.1210/jc.2014-2569 10.1016/j.steroids.2011.12.017 10.1210/edrv-11-1-80 10.1530/REP-15-0044 10.1186/s13048-015-0139-1 10.1210/clinem/dgaa060 10.1016/j.mce.2016.11.009 10.1007/s43032-020-00194-7 10.1097/PAP.0b013e318234aaed 10.1210/jc.2011-2366 10.1007/s00109-019-01809-6 10.1159/000486784 10.18632/oncotarget.24821 10.21873/invivo.11764 10.21873/invivo.11981 10.1152/ajpendo.00359.2018 10.1186/s13048-017-0359-7 10.1189/jlb.0708395 10.1530/REP-12-0217 10.1111/j.1600-0897.2009.00792.x 10.1210/en.2017-00495 10.1093/humrep/dev055 10.1016/j.ando.2019.10.002 10.1111/aji.13170 10.1177/1933719116653681 10.1155/2009/465203 10.3109/09513590.2012.760195 10.1177/1179558119861936 10.1093/biolre/ioz180 10.1007/s12020-019-01972-3 10.1093/molehr/gap030 10.1038/ejcn.2012.220 10.1016/j.lfs.2020.117830 10.1016/j.lfs.2020.117344 10.1111/j.1476-5381.2009.00450.x 10.1016/j.metabol.2015.08.010 10.1186/s12986-018-0306-7 10.1096/fj.08-109033 10.1080/09513590.2019.1633297 10.1093/humrep/dey029 10.1210/er.2011-1034 10.1038/414799a 10.1210/jc.2017-02459 10.1111/cen.12099 10.1111/cen.13808 10.1016/j.mce.2018.05.010 10.1177/1933719117732157 10.1016/j.steroids.2011.12.003 10.1007/s43032-019-00026-3 10.1177/1535370215584937 10.2478/jomb-2018-0008 10.1016/j.fertnstert.2011.03.021 10.1016/j.fertnstert.2016.11.009 10.1016/j.fertnstert.2016.07.1069 10.2174/13816128112092482 10.1097/gme.0b013e3181e170af 10.1186/s12958-017-0227-8 10.1210/er.2015-1104 10.1016/j.metabol.2018.11.002 10.1093/humrep/deu114 10.1016/j.cyto.2019.04.006 10.3109/09513590.2014.951321 10.1177/1933719118820466 10.1159/000491086 10.1007/s00404-017-4295-y 10.1371/journal.pone.0217095 10.1530/REP-18-0518 10.1152/ajpendo.00162.2019 10.1007/s00125-016-4053-x 10.1210/en.2017-03082 10.1056/NEJM198807283190401 10.2337/diab.38.9.1165 10.1080/13813455.2018.1499120 10.1038/ijo.2016.154
Reproductive Sciences (Thousand Oaks, Calif.); Jiang NX, Li XL
May 29th, 2021 - Polycystic ovary syndrome (PCOS) is a mysterious and complicated endocrine disease with the combination of metabolic, reproductive, psychological dysfunctions. Impaired endometrial receptivity and ovulation disorders/anovulation are both important...
Guidelines 1 results
https://doi.org/10.1210/jc.2017-00131
The Journal of Clinical Endocrinology and Metabolism; Gordon CM, Ackerman KE et. al.
Apr 4th, 2017 - The American Society for Reproductive Medicine, the European Society of Endocrinology, and the Pediatric Endocrine Society. This guideline was funded by the Endocrine Society. To formulate clinical practice guidelines for the diagnosis and treatme...
Drugs 3 results see all →
Clinicaltrials.gov 44 results
https://clinicaltrials.gov/ct2/show/NCT02523898
Mar 18th, 2020 - Introduction: PCOS is the most common cause of anovulatory infertility which affects 12-21% of the population. This percentage may vary according to the criteria used and population studied.Hyperandrogenism, chronic anovulation, and occasionally o...
https://clinicaltrials.gov/ct2/show/NCT03709849
Jan 10th, 2019 - Anovulation is one of the main causes of female infertility. Anovulatory infertility account for a proportion of 25-30% in whole female infertility. In western medicine, hormone induced ovulation and assisted reproduction technology are two main w...
https://clinicaltrials.gov/ct2/show/NCT03545945
Sep 26th, 2018 - Patients with chronic anovulation presenting to the IVF clinic for subfertility treatment are at increased risk of endometrial hyperplasia and carcinoma.They are often subjected to endometrial biopsy to rule out any underlying changes such as endo...
https://clinicaltrials.gov/ct2/show/NCT01266421
Aug 10th, 2018 - Endometriosis is a common, chronic, gynecological disease characterized by pain and impaired fertility. It causes chronic inflammation, ovarian cyst formation, fibrosis and adhesions. Symptoms seem to respond to decreased circulating estrogen. The...
https://clinicaltrials.gov/ct2/show/NCT03489668
Aug 9th, 2018 - 50-100 PCOS and 50-100 normal women matched for age (<37 yr) and BMI (<35) will be studied. PCOS and normal women in the mid-follicular phase (day 5-7) of the menstrual cycle will receive an iv injection of hCG as previously described (see Experim...
News 71 results
https://www.medscape.com/viewarticle/953912
Jun 29th, 2021 - No link between fertility treatment and an increase in the risk for breast cancer was found in the largest study of the issue to date. This study "provides the evidence needed to reassure women and couples seeking fertility treatments," commented ...
https://www.medscape.com/viewarticle/947684
Mar 18th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Women with polycystic ovary syndrome (PCOS) face an almost 30% increased risk for COVID-19 compared with unaffected women, even after adjusting fo...
https://www.mdedge.com/obgyn/article/207161/gynecology/acog-advises-bleeding-disorder-screening-teens-heavy-menstruation?channel=27970
Heidi Splete
Aug 27th, 2019 - Adolescent girls with heavy menstrual bleeding should be assessed for bleeding disorders, according to a Committee Opinion issued by the American College of Obstetricians and Gynecologists. A bleeding disorder is secondary only to anovulation as a.
https://www.medscape.com/viewarticle/908873
Feb 14th, 2019 - Link Between Body Weight and Fertility The prevalence of obesity has tripled since 1975, and in 2016 it was estimated that 1.9 billion adults worldwide were overweight or obese.[1] On the basis of 2013-2014 data, 66.9% of US women were overweight ...
https://www.medscape.com/viewarticle/904787
Nov 19th, 2018 - Uterine Fibroids and Heavy Menstrual Bleeding A typical menstruation occurs every 21-35 days (typically around 28 days) and lasts for 2-7 days. Excessive bleeding (heavy flow, clots) or menstruation that lasts longer than 7 days could cause anemia...
